OSPREY THERAPEUTICS

Serial Number 87725257
606

Registration Progress

Application Filed
Dec 18, 2017
Under Examination
Jul 10, 2018
Approved for Publication
May 15, 2018
Published for Opposition
May 15, 2018
Registered

Trademark Image

OSPREY THERAPEUTICS

Basic Information

Serial Number
87725257
Filing Date
December 18, 2017
Published for Opposition
May 15, 2018
Abandonment Date
August 16, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 16, 2021
Classes
005

Rights Holder

Ionis Pharmaceuticals, Inc.

03
Address
2855 Gazelle Court
Carlsbad, CA 92010

Ownership History

Ionis Pharmaceuticals, Inc.

Original Applicant
03
Carlsbad, CA

Ionis Pharmaceuticals, Inc.

Owner at Publication
03
Carlsbad, CA

Legal Representation

Attorney
Anne H. Peck

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Aug 16, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 16, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 31, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 30, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 30, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 11, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 30, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 3, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 3, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 11, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 10, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 8, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 4, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 4, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 4, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 10, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 15, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 15, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 25, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 4, 2018 ALIE A ASSIGNED TO LIE Loading...
Mar 30, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 30, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 30, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 27, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 4, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 21, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; injectable drugs for reducing production of transthyretin; antisense drugs

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"